Understanding the mechanism of cancer cell metastasis is crucial for targeted cancer diagnosis and research. But this process is still not fully understood mainly because of lack of in vitro cell culture models that precisely mimic the physiological complexities of cancer cell intravascular flows, invasion, adhesion, metastasis, angiogenesis and migration to specific sites. Microand nanoscale technologies offer a promising tool for such purpose. This special issue broadly covers the topics of cell microenvironment, biological surface modifications, multifunctional nanoparticles and nanosensors, microfluidics, molecular detection as well as multistage targeting strategies for cancer. In particular, it focuses on investigating how we can harness the power of microand nanotechnologies to radically change the way we diagnose and treat cancer. This includes both in vivo and ex vivo technologies. For in vivo applications, biosensors would have the capability of detecting tumors andmetastatic lesions that are far smaller than those detectable using conventional technologies. Novel and multi-functional nanodevices will be capable of detecting cancer at its earliest stages, pinpointing its location within the body, delivering anticancer drugs specifically to malignant cells, and determining if these drugs are effective. In addition, functionalized nanoparticles would deliver multiple therapeutic agents to tumor sites in order to simultaneously attack multiple points in the pathways involved in cancer. Such nano-therapeutics are expected to increase the efficacy of drugs while dramatically reducing potential side effects. For ex vivo application, the tumor microenvironment and circulating tumor cells can be studied. Together, such innovative approaches can provide information on potential early diagnosis as well as whether a given therapy is working as expected. The group of Fischbach et al. reviews recent efforts in modulating the tumor microenvironment to develop in vitro tumor models for cancer pathogenesis and drug discovery. The work covers some of the recent landmark efforts towards this direction or micro-tumor engineering with focus on tissue microstructure organization and surrounding mass transport behavior using biomimetic approaches. The authors thus highlight the immense potential of microfabrication techniques for such cancer pathogenesis applications. In order to understand the recent advances in microfluidic technologies for cancer research, Nagrath et al. have identified four critical areas of research: cancer cell isolation, molecular diagnostics, tumor biology, and high-throughput screening for therapeutics. Cancer cell isolation can be further subcategorized into two major techniques: immunoaffinity-based isolation and size-based separation. Other methods include hydrodynamic focusing and dielectrophoresis. For the cancer cell isolation technologies, Ohnaga et al. developed polymeric microfluidic devices for the isolation of circulating tumor cells using microposts coated with anti-epithelial cell adhesion olecule antibody, and a flow system to capture tumor cells using an esophageal cancer cell line, KYSE220, dispersed in phosphate-buffered saline or mononuclear cell separation from whole blood. Recently, He et al. developed biocompatible nano-films composed of TiO2 nanoparticles to enhance topographic interactions between the nanofilm substrate surface and cell surface. The surface of the TiO2 nanoparticles is chemically modified to enable functionalization of anti-EpCAM antibodies. The J. X. J. Zhang (*) Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA e-mail: john.zhang@engr.utexas.edu